Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.

Suppr

超能文献

作者信息

Nelson D A, Vates T S, Thomas R B

出版信息

Acta Neurol Scand. 1973;49(2):176-88. doi: 10.1111/j.1600-0404.1973.tb01289.x.

DOI:10.1111/j.1600-0404.1973.tb01289.x

PMID:4740461

Abstract

摘要

相似文献

Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.

Acta Neurol Scand. 1973;49(2):176-88. doi: 10.1111/j.1600-0404.1973.tb01289.x.

Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.

Ann Allergy. 1967 Dec;25(12):665-72.

Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.

Del Med J. 1977 Jun;49(6):331-43.

Intrathecal methylprednisolone for postherpetic neuralgia.

N Engl J Med. 2001 Mar 29;344(13):1019; author reply 1021-2.

Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis.

J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1124-8. doi: 10.1136/jnnp.39.11.1124.

[Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].

Cesk Neurol Neurochir. 1975 Dec;38(6):338-45.

Chemical meningitis related to intrathecal corticosteroid therapy.

South Med J. 1977 Oct;70(10):1241-3. doi: 10.1097/00007611-197710000-00025.

Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.

Trans Am Neurol Assoc. 1970;95:243-4.

Intrathecal Depo-Medrol: a literature review.

Clin J Pain. 1992 Mar;8(1):49-56; discussion 57-8.

[Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].

Minerva Med. 1974 Sep 19;65(65):3407-11.

引用本文的文献

Triamcinolone-loaded nanocarriers: a novel strategy to mitigate cognitive and emotional sequelae induced by traumatic brain injury via modulation of oxidative stress.

Front Behav Neurosci. 2025 Aug 12;19:1638417. doi: 10.3389/fnbeh.2025.1638417. eCollection 2025.

Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Eur Spine J. 2019 Jan;28(1):21-30. doi: 10.1007/s00586-017-5387-x. Epub 2017 Nov 18.

Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.

Mol Pain. 2017 Jan;13:1744806917697006. doi: 10.1177/1744806917697006.

Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.

Mult Scler Int. 2011;2011:219049. doi: 10.1155/2011/219049. Epub 2011 Jun 26.

Neurology-epitomes of progress: treatment of multiple sclerosis with adrenal cortical steroids.

West J Med. 1977 Aug;127(2):133-4.

Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports.

J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):433-43. doi: 10.1136/jnnp.70.4.433.

Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):209-40. doi: 10.1007/BF03259883.

Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.

Ital J Neurol Sci. 1989 Feb;10(1):19-32. doi: 10.1007/BF02333869.

Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.

J Neurol. 1992 Jan;239(1):31-5. doi: 10.1007/BF00839208.

Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis.

J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1124-8. doi: 10.1136/jnnp.39.11.1124.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验